Caprotec Bioanalytics (Germany) a commercial-stage company focused on a mass spec technology of multifunctional small molecules used to target, capture and isolate proteins based on their functionality, closed a $4.9M Series B financing. Participants include Creathor Venture, IBB Beteiligungsgesellschaft and ERP Startfonds.